Table 2.

Study assessments and time points

Study Assessments/Testing	Baseline	Day
		-2	0	7	14	21	28	35	42	Next Clinic Visit	100
Demographics (patient-, disease-, and treatment-related)	X
Additional descriptive outcomes				X	X	X	X				X
Socioeconomic status	X
Hospital Anxiety and Depression Scale (HADS)	X		X	X	X	X	X
Blood draw for gene expression analysis	X	X					X
Pregnancy test for females of child bearing potential	X
Toxicity			X	X	X	X	X	Xa	Xa
Assessment of adherenceb		X					X			X
Heart rate and blood pressure	X		X	X	X	X	X			X
Myeloma response assessment											X

^aPropranolol group only

^bAdherence assessed weekly or monthly based on number of pills prescribed